Randomized, two arm, controlled study to compare the efficacy of oral ibandronate treatment versus intravenous zoledronate in patients with symptomatic Multiple Myeloma.

Trial Profile

Randomized, two arm, controlled study to compare the efficacy of oral ibandronate treatment versus intravenous zoledronate in patients with symptomatic Multiple Myeloma.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Ibandronic acid; Zoledronic acid
  • Indications Bone metastases; Fracture
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 12 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top